These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3728458)

  • 21. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new Italian family with severe prekallikrein deficiency. Desmopressin-induced fibrinolysis and coagulation changes in homozygous and heterozygous members.
    Castaman G; Ruggeri M; Rodeghiero F
    Ric Clin Lab; 1990; 20(4):239-44. PubMed ID: 2127471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
    Goldsmith GH
    J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family.
    Yang J; Fan L; Qiao Y; Zhao Y; Zhu T
    J Thromb Thrombolysis; 2020 Nov; 50(4):989-994. PubMed ID: 32185598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of high molecular weight kininogen deficiency--problem of its laboratory diagnosis and low molecular weight kininogen].
    Komiyama Y; Nishikado H; Egawa H; Murata K; Munakata M; Teraoka A; Okubo S; Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):1047-53. PubMed ID: 3324605
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies of measuring condition of activated partial thromboplastin time and contact factors in experimental animals].
    Noguchi M; Fujii T; Minamide S
    Jikken Dobutsu; 1989 Jul; 38(3):221-9. PubMed ID: 2792204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Disorders in the contact phase system of blood coagulation as a cause of increased partial thromboplastin time].
    Siegert G; Plat M
    Z Gesamte Inn Med; 1988 May; 43(9):228-31. PubMed ID: 3407236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.
    Asmis LM; Sulzer I; Furlan M; Lämmle B
    Thromb Res; 2002 Mar; 105(6):463-70. PubMed ID: 12091043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated partial thromboplastin time and minor coagulopathies.
    Hathaway WE; Assmus SL; Montgomery RR; Dubansky AS
    Am J Clin Pathol; 1979 Jan; 71(1):22-5. PubMed ID: 420168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor deficiency apparently related to the Fitzgerald trait: the first cases in Japan.
    Hayashi H; Koya H; Kitajima K; Kimura I
    Acta Med Okayama; 1978 Apr; 32(1):81-3. PubMed ID: 148837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the heredity of kininogen deficiency in brown Norway Katholiek strain rats.
    Hayashi I; Fujie H; Mita M; Oh-ishi S
    Life Sci; 1992; 51(2):135-42. PubMed ID: 1614279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.